Overall Concerns and Perceptions About Innovative Private Pharmacy Distribution Channels, by Stakeholder Group (N=15), Lusaka, Zambia, 2022
| Stakeholder Group | Primary Concerns | Secondary Concerns | Innovation Stance |
|---|---|---|---|
| Innovators (n=5) | Cost barriers (5/5) | Regulatory flexibility (4/5) | Highly positive |
| Wholesalers (n=3) | Distribution efficiency (3/3) | Technology infrastructure (2/3) | Moderately positive |
| Retailers (n=3) | Medicine availability (3/3) | Implementation costs (2/3) | Positive |
| Regulator/National agency (n=3) | Quality assurance (3/3) | Authentication systems (2/3) | Cautiously positive |
| Supply chain expert (n=1) | Technology implementation (1/1) | Infrastructure challenges (1/1) | Positive |